Evolving Significance of Tumor-Normal Sequencing in Cancer Care

被引：37

作者：

Mandelker, Diana ^{[1
]}

Ceyhan-Birsoy, Ozge ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10065 USA

来源：

TRENDS IN CANCER | 2020年 / 6卷 / 01期

关键词：

CLONAL HEMATOPOIESIS; GERMLINE MUTATIONS; DNA; GENES; GUIDELINE; MOSAICISM; VARIANTS; GENOMICS; SOCIETY;

D O I：

10.1016/j.trecan.2019.11.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Molecular tests assist at various stages of cancer patient management, including providing diagnosis, predicting prognosis, identifying therapeutic targets, and determining hereditary cancer risk. The current testing paradigm involves germline testing in a subset of patients determined to be at high risk for having a hereditary cancer syndrome, and tumor-only sequencing for treatment decisions in advanced cancer patients. A major limitation of tumor-only sequencing is its inability to distinguish germline versus somatic mutations. Tumor-normal sequencing has emerged as a comprehensive analysis for both hereditary cancer predisposition and somatic profiling. Here, we review recent studies involving tumor-normal sequencing, discuss its benefits in clinical care, challenges for its implementation, and novel insights it has provided regarding tumor biology and germline contribution to cancer.

引用

页码：31 / 39

页数：9

共 54 条

[31] Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing [J].

Mandelker, Diana ;

Zhang, Liying ;

Kemel, Yelena ;

Stadler, Zsofia K. ;

Joseph, Vijai ;

Zehir, Ahmet ;

Pradhan, Nisha ;

Arnold, Angela ;

Walsh, Michael F. ;

Li, Yirong ;

Balakrishnan, Anoop R. ;

Syed, Aijazuddin ;

Prasad, Meera ;

Nafa, Khedoudja ;

Carlo, Maria I. ;

Cadoo, Karen A. ;

Sheehan, Meg ;

Fleischut, Megan H. ;

Salo-Mullen, Erin ;

Trottier, Magan ;

Lipkin, Steven M. ;

Lincoln, Anne ;

Mukherjee, Semanti ;

Ravichandran, Vignesh ;

Cambria, Roy ;

Galle, Jesse ;

Abida, Wassim ;

Arcila, Marcia E. ;

Benayed, Ryma ;

Shah, Ronak ;

Yu, Kenneth ;

Bajorin, Dean F. ;

Coleman, Jonathan A. ;

Leach, Steven D. ;

Lowery, Maeve A. ;

Garcia-Aguilar, Julio ;

Kantoff, Philip W. ;

Sawyers, Charles L. ;

Dickler, Maura N. ;

Saltz, Leonard ;

Motzer, Robert J. ;

O'Reilly, Eileen M. ;

Scher, Howard I. ;

Baselga, Jose ;

Klimstra, David S. ;

Solit, David B. ;

Hyman, David M. ;

Berger, Michael F. ;

Ladanyi, Marc ;

Robson, Mark E. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (09) :825-835

[32] Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol [J].

Meric-Bernstam, F. ;

Brusco, L. ;

Daniels, M. ;

Wathoo, C. ;

Bailey, A. M. ;

Strong, L. ;

Shaw, K. ;

Lu, K. ;

Qi, Y. ;

Zhao, H. ;

Lara-Guerra, H. ;

Litton, J. ;

Arun, B. ;

Eterovic, A. K. ;

Aytac, U. ;

Routbort, M. ;

Subbiah, V. ;

Janku, F. ;

Davies, M. A. ;

Kopetz, S. ;

Mendelsohn, J. ;

Mills, G. B. ;

Chen, K. .

ANNALS OF ONCOLOGY, 2016, 27 (05) :795-800

[33] Misdiagnosis of Li-Fraumeni Syndrome in a Patient With Clonal Hematopoiesis and a Somatic TP53 Mutation [J].

Mitchell, Rachel L. ;

Kosche, Cory ;

Burgess, Kelly ;

Wadhwa, Shreya ;

Buckingham, Lela ;

Ghai, Ritu ;

Rotmensch, Jacob ;

Klapko, Oleksandra ;

Usha, Lydia .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (05) :461-466

[34] Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers [J].

Nones, K. ;

Johnson, J. ;

Newell, F. ;

Patch, A. M. ;

Thorne, H. ;

Kazakoff, S. H. ;

de Luca, X. M. ;

Parsons, M. T. ;

Ferguson, K. ;

Reid, L. E. ;

Reed, A. E. McCart ;

Srihari, S. ;

Lakis, V ;

Davidson, A. L. ;

Mukhopadhyay, P. ;

Holmes, O. ;

Xu, Q. ;

Wood, S. ;

Leonard, C. ;

Beesley, J. ;

Harris, J. M. ;

Barnes, D. ;

Degasperi, A. ;

Ragan, M. A. ;

Spurdle, A. B. ;

Khanna, K. K. ;

Lakhani, S. R. ;

Pearson, J., V ;

Nik-Zainal, S. ;

Chenevix-Trench, G. ;

Waddell, N. ;

Simpson, P. T. .

ANNALS OF ONCOLOGY, 2019, 30 (07) :1071-1079

[35] Systematic discovery of germline cancer predisposition genes through the identification of somatic second hits [J].

Park, Solip ;

Supek, Fran ;

Lehner, Ben .

NATURE COMMUNICATIONS, 2018, 9

[36] Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors [J].

Parsons, D. Williams ;

Roy, Angshumoy ;

Yang, Yaping ;

Wang, Tao ;

Scollon, Sarah ;

Bergstrom, Katie ;

Kerstein, Robin A. ;

Gutierrez, Stephanie ;

Petersen, Andrea K. ;

Bavle, Abhishek ;

Lin, Frank Y. ;

Lopez-Terrada, Dolores H. ;

Monzon, Federico A. ;

Hicks, M. John ;

Eldin, Karen W. ;

Quintanilla, Norma M. ;

Adesina, Adekunle M. ;

Mohila, Carrie A. ;

Whitehead, William ;

Jea, Andrew ;

Vasudevan, Sanjeev A. ;

Nuchtern, Jed G. ;

Ramamurthy, Uma ;

McGuire, Amy L. ;

Hilsenbeck, Susan G. ;

Reid, Jeffrey G. ;

Muzny, Donna M. ;

Wheeler, David A. ;

Berg, Stacey L. ;

Chintagumpala, Murali M. ;

Eng, Christine M. ;

Gibbs, Richard A. ;

Plon, Sharon E. .

JAMA ONCOLOGY, 2016, 2 (05) :616-624

[37] Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors [J].

Ptashkin, Ryan N. ;

Mandelker, Diana L. ;

Coombs, Catherine C. ;

Bolton, Kelly ;

Yelskaya, Zarina ;

Hyman, David M. ;

Solit, David B. ;

Baselga, Jose ;

Arcila, Maria E. ;

Ladanyi, Marc ;

Zhang, Liying ;

Levine, Ross L. ;

Berger, Michael F. ;

Zehir, Ahmet .

JAMA ONCOLOGY, 2018, 4 (11) :1589-1593

[38] Realizing the promise of cancer predisposition genes [J].

Rahman, Nazneen .

NATURE, 2014, 505 (7483) :302-308

[39] American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility [J].

Robson, Mark E. ;

Bradbury, Angela R. ;

Arun, Banu ;

Domchek, Susan M. ;

Ford, James M. ;

Hampel, Heather L. ;

Lipkin, Stephen M. ;

Syngal, Sapna ;

Wollins, Dana S. ;

Lindor, Noralane M. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (31) :3660-+

[40] Tumor mutational load predicts survival after immunotherapy across multiple cancer types [J].

Samstein, Robert M. ;

Lee, Chung-Han ;

Shoushtari, Alexander N. ;

Hellmann, Matthew D. ;

Shen, Ronglai ;

Janjigian, Yelena Y. ;

Barron, David A. ;

Zehir, Ahmet ;

Jordan, Emmet J. ;

Omuro, Antonio ;

Kaley, Thomas J. ;

Kendall, Sviatoslav M. ;

Motzer, Robert J. ;

Hakimi, A. Ari ;

Voss, Martin H. ;

Russo, Paul ;

Rosenberg, Jonathan ;

Iyer, Gopa ;

Bochner, Bernard H. ;

Bajorin, Dean F. ;

Al-Ahmadie, Hikmat A. ;

Chaft, Jamie E. ;

Rudin, Charles M. ;

Riely, Gregory J. ;

Baxi, Shrujal ;

Ho, Alan L. ;

Wong, Richard J. ;

Pfister, David G. ;

Wolchok, Jedd D. ;

Barker, Christopher A. ;

Gutin, Philip H. ;

Brennan, Cameron W. ;

Tabar, Viviane ;

Mellinghoff, Ingo K. ;

DeAngelis, Lisa M. ;

Ariyan, Charlotte E. ;

Lee, Nancy ;

Tap, William D. ;

Gounder, Mrinal M. ;

D'Angelo, Sandra P. ;

Saltz, Leonard ;

Stadler, Zsofia K. ;

Scher, Howard I. ;

Baselga, Jose ;

Razavi, Pedram ;

Klebanoff, Christopher A. ;

Yaeger, Rona ;

Segal, Neil H. ;

Ku, Geoffrey Y. ;

DeMatteo, Ronald P. .

NATURE GENETICS, 2019, 51 (02) :202-+

← 1 2 3 4 5 6 →